Physical Comorbidity and Healthcare Utilization in People with Schizophrenia: a systematic review
##plugins.themes.bootstrap3.article.main##
Abstract
Introduction. Schizophrenia is a mental health condition that can lead to significant disability and have a major impact on social and occupational functioning. It tends to decrease life expectancy, which could be attributed to a variety of factors, including poor health habits, barriers to healthcare access, and the stigmatization of mental illness.
Objective. The main aim of this systematic review is to examine the physical comorbidity of these patients, and their health service utilization.
Method. The protocol has been registered with the PROSPERO database (CRD42020139972) and follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A search of PubMed/MEDLINE, EMBASE, Scopus, Web of Science, PsycINFO, Cochrane Library, and ProQuest Health Research Premium Collection yielded 317 articles, 57 of which were selected.
Results. The mortality rate of people with schizophrenia is often at least twice that of the general population. In addition, these individuals may be susceptible to other physical health conditions that can significantly shorten their lifespan: cardiovascular and respiratory diseases, diabetes mellitus, oncologic diseases, and chronic infections. Complications during hospitalization and prolonged length of stay due to comorbidities may impede their access to essential healthcare.
Discussion and conclusion. Enhancing the healthcare system is crucial to providing adequate care for these patients. Adopting positive lifestyle choices, reducing substance dependence, and abstaining from unconventional antipsychotics can bolster their life expectancy. It is therefore crucial to implement intervention strategies while training professionals to detect and manage physical comorbidities associated with this disorder.
References
Attar, R., Berg Johansen, M., Valentin, J. B., Aagaard, J., & Jensen, S. E. (2017). Treatment following myocardial infarction in patients with schizophrenia. PloS One, 12(12), e0189289. https://doi.org/10.1371/journal.pone.0189289
Bailey, E. A., Wirtalla, C., Sharoky, C. E., & Kelz, R. R. (2018). Disparities in operative outcomes in patients with comorbid mental illness. Surgery, 163(4), 667-671. https://doi.org/10.1016/j.surg.2017.09.029
Bauer-Staeb, C., Jörgensen, L., Lewis, G., Dalman, C., Osborn, D. P. J., & Hayes, J. F. (2017). Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden. The Lancet - Psychiatry, 4(9), 685-693. https://doi.org/10.1016/S2215-0366(17)30253-5
Bernardo, M., Rico-Villademoros, F., García-Rizo, C., Rojo, R., & Gómez-Huelgas, R. (2021). Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies. Advances in Therapy, 38(5), 2491-2512. https://doi.org/10.1007/s12325-021-01689-8
Bitter, I., Czobor, P., Borsi, A., Fehér, L., Nagy, B. Z., Bacskai, M., Rakonczai, P., Hegyi, R., Németh, T., Varga, P., Gimesi-Országh, J., Fadgyas-Freyler, P., Sermon, J., … Takács, P. (2017). Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. European psychiatry, 45, 97-103. https://doi.org/10.1016/j.eurpsy.2017.05.022
Bodén, R., Molin, E., Jernberg, T., Kieler, H., Lindahl, B., & Sundström, J. (2015). Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study. Journal of Internal Medicine, 277(6), 727-736. https://doi.org/10.1111/joim.12329
Bouza, C., López-Cuadrado, T., & Amate, J. M. (2010a). Hospital admissions due to physical disease in people with schizophrenia: a national population-based study. General Hospital Psychiatry, 32(2), 156-163. https://doi.org/10.1016/j.genhosppsych.2009.11.014
Bouza, C., López-Cuadrado, T., & Amate, J. M. (2010b). Physical disease in schizophrenia: a population-based analysis in Spain. BMC Public Health, 10, 745. https://doi.org/10.1186/1471-2458-10-745
Bradford, D. W., Goulet, J., Hunt, M., Cunningham, N. C., & Hoff, R. (2016). A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer. The Journal of Clinical Psychiatry, 77(12), e1626-e1630. https://doi.org/10.4088/JCP.15m10281
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2017). Physical Health, Medication, and Healthcare Utilization among 70-Year-Old People with Schizophrenia: A Nationwide Danish Register Study. American Journal of Geriatric Psychiatry, 25(5), 500-509. doi: 10.1016/j.jagp.2016.12.015
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2019). Excess medical comorbidity and mortality across the lifespan in schizophrenia: A nationwide Danish register study. Schizophrenia Research, 206, 347-354. https://doi.org/10.1016/j.schres.2018.10.020
Carney, C. P., Jones, L., & Woolson, R. F. (2006). Medical comorbidity in women and men with schizophrenia: a population-based controlled study. Journal of General Internal Medicine, 21(11), 1133-1137. https://doi.org/10.1111/j.1525-1497.2006.00563.x
Chen, P. H., Tsai, S. Y., Pan, C. H., Chang, H. M., Chen, Y. L., Su, S. S., Chen. C. C., & Kuo, C. J. (2021). Age Effect on Incidence, Physical, and Psychiatric Comorbidity for Sudden Cardiac Death in Schizophrenia: Effet de l’âge sur l’incidence, la comorbidité physique et psychiatrique de la mort cardiaque subite dans la schizophrénie. Canadian Journal of Psychiatry / Revue Canadienne de Psychiatrie, 66(4), 367-375. https://doi.org/10.1177/0706743720948429
Cloutier, M., Aigbogun, M. S., Guerin, A., Nitulescu, R., Ramanakumar, A. V., Kamat, S. A., DeLucia, M., Duffy, R., Legacy, S. N., Henderson, C., Francois, C., & Wu, E. (2016). The Economic Burden of Schizophrenia in the United States in 2013. The Journal of Clinical Psychiatry, 77(6), 764-771. https://doi.org/10.4088/JCP.15m10278
Contreras-Shannon, V., Heart, D. L., Paredes, R. M., Navaira, E., Catano, G., Maffi, S. K., & Walss-Bass, C. (2013). Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PloS One, 8(3), e59012. https://doi.org/10.1371/journal.pone.0059012
Copeland, L. A., Mortensen, E. M., Zeber, J. E., Pugh, M. J., Restrepo, M. I., & Dalack, G. W. (2007). Pulmonary disease among inpatient decedents: Impact of schizophrenia. Progress in Neuro-psychopharmacology & Biological Psychiatry, 31(3), 720-726. https://doi.org/10.1016/j.pnpbp.2007.01.008
Copeland, L. A., Zeber, J. E., Rosenheck, R. A., & Miller, A. L. (2006). Unforeseen inpatient mortality among veterans with schizophrenia. Medical Care, 44(2), 110-116. https://doi.org/10.1097/01.mlr.0000196973.99080.fb
Correll, C. U., Ng-Mak, D. S., Stafkey-Mailey, D., Farrelly, E., Rajagopalan, K., & Loebel, A. (2017). Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis. Annals of General Psychiatry, 16, 9. https://doi.org/10.1186/s12991-017-0133-7
Correll, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P., Taipale, H., & Tiihonen, J. (2022). Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry, 21(2), 248-271. https://doi.org/10.1002/wps.20994
Dalton, S. O., Suppli, N. P., Ewertz, M., Kroman, N., Grassi, L., & Johansen, C. (2018). Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011. Breast (Edinburgh, Scotland), 40, 170-176. https://doi.org/10.1016/j.breast.2018.06.002
Daumit, G. L., Pronovost, P. J., Anthony, C. B., Guallar, E., Steinwachs, D. M., & Ford, D. E. (2006). Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Archives of General Psychiatry, 63(3), 267-272. https://doi.org/10.1001/archpsyc.63.3.267
DE Hert, M., Correll, C. U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I., Detraux, J., Gautam, S., Möller, H. J., Ndetei, D. M., Newcomer, J. W., Uwakwe, R., & Leucht, S. (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1), 52-77. https://doi.org/10.1002/j.2051-5545.2011.tb00014.x
Douzenis, A., Seretis, D., Nika, S., Nikolaidou, P., Papadopoulou, A., Rizos, E. N., Christodoulou, C., Tsopelas, C., Mitchell, D., & Lykouras, L. (2012). Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. BMC Health Services Research, 12, 166. https://doi.org/10.1186/1472-6963-12-166
D’Avanzo, B., La Vecchia, C., & Negri, E. (2003). Mortality in long-stay patients from psychiatric hospitals in Italy--results from the Qualyop Project. Social Psychiatry and Psychiatric Epidemiology, 38(7), 385-389. https://doi.org/10.1007/s00127-003-0646-z
Foley, D. L., Mackinnon, A., Morgan, V. A., Watts, G. F., Castle, D. J., Waterreus, A., & Galletly, C. A. (2016). Common familial risk factors for schizophrenia and diabetes mellitus. The Australian and New Zealand Journal of Psychiatry, 50(5), 488-494. https://doi.org/10.1177/0004867415595715
Fond, G., Salas, S., Pauly, V., Baumstarck, K., Bernard, C., Orleans, V., Llorca, P. M., Lancon, C., Auquier, P., & Boyer, L. (2019). End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database. The Lancet - Public Health, 4(11), e583-e591. https://doi.org/10.1016/S2468-2667(19)30187-2
Gabilondo, A., Alonso-Moran, E., Nuño-Solinis, R., Orueta, J. F., & Iruin, A. (2017). Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset. Journal of Psychosomatic Research, 93, 102-109. https://doi.org/10.1016/j.jpsychores.2016.12.011
Goldman, L. S. (1999). Medical illness in patients with schizophrenia. The Journal of Clinical Psychiatry, 60(Suppl 21), 10-15.
Goueslard, K., Petit, J. M., Cottenet, J., Chauvet-Gelinier, J. C., Jollant, F., & Quantin, C. (2018). Increased Risk of Rehospitalization for Acute Diabetes Complications and Suicide Attempts in Patients with Type 1 Diabetes and Comorbid Schizophrenia. Diabetes Care, 41(11), 2316-2321. https://doi.org/10.2337/dc18-0657
Guadalajara, H., Lopez-Fernandez, O, León Arellano, M., Domínguez-Prieto, V., Caramés, C., & Garcia-Olmo, D. (2022). The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate. Pharmaceuticals, 15(2), 215. https://doi.org/10.3390/ph15020215
Gur, S., Weizman, S., Stubbs, B., Matalon, A., Meyerovitch, J., Hermesh, H., & Krivoy, A. (2018). Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study. Psychiatry Research, 260, 177-181. https://doi.org/10.1016/j.psychres.2017.11.042
Gyllensten, A. L., Ovesson, M. N., Hedlund, L., Ambrus, L., & Tornberg, Å. (2020). To increase physical activity in sedentary patients with affective - or schizophrenia spectrum disorders - a clinical study of adjuvant physical therapy in mental health. Nordic Journal of Psychiatry, 74(1), 73-82. https://doi.org/10.1080/08039488.2019.1669706
Hauck, T. S., Liu, N., Wijeysundera, H. C., & Kurdyak, P. (2020). Mortality and Revascularization among Myocardial Infarction Patients with Schizophrenia: A Population-Based Cohort Study. Canadian Journal of Psychiatry / Revue Canadienne de Psychiatrie, 65(7), 454-462. https://doi.org/10.1177/0706743720904845
Hayes, J. F., Marston, L., Walters, K., King, M. B., & Osborn, D. P. J. (2017). Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014. The British Journal of Psychiatry: The Journal of Mental Science, 211(3), 175-181. https://doi.org/10.1192/bjp.bp.117.202606
Heiberg, I. H., Jacobsen, B. K., Balteskard, L., Bramness, J. G., Naess, Ø., Ystrom, E., Reichborn-Kjennerud, T., Hultman, C. M., Nesvåg, R., & Høye, A. (2019). Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness. Acta Psychiatrica Scandinavica, 139(6), 558-571. https://doi.org/10.1111/acps.13017
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017). Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. The Lancet - Psychiatry, 4(4), 295-301. https://doi.org/10.1016/S2215-0366(17)30078-0
Hou, P. Y., Hung, G. C., Jhong, J. R., Tsai, S. Y., Chen, C. C., & Kuo, C. J. (2015). Risk factors for sudden cardiac death among patients with schizophrenia. Schizophrenia Research, 168(1-2), 395-401. https://doi.org/10.1016/j.schres.2015.07.015
Huang, C. J., Hsieh, H. M., Tu, H. P., Jiang, H. J., Wang, P. W., & Lin, C. H. (2018). Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics. European Psychiatry, 54, 102-108. https://doi.org/10.1016/j.eurpsy.2018.08.002
Hughes, J. R. (1993). Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. The Journal of Clinical Psychiatry, 54(3), 109-114.
Ishikawa, H., Yasunaga, H., Matsui, H., Fushimi, K., & Kawakami, N. (2016). Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study. The British Journal of Psychiatry: The Journal of Mental Science, 208(3), 239-244. https://doi.org/10.1192/bjp.bp.114.156265
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996). Medical comorbidity in schizophrenia. Schizophrenia Bulletin, 22(3), 413-430. https://doi.org/10.1093/schbul/22.3.413
Jørgensen, M., Mainz, J., Lange, P., & Paaske Johnsen, S. (2018). Quality of care and clinical outcomes of chronic obstructive pulmonary disease in patients with schizophrenia. A Danish nationwide study. International Journal for Quality in Health Care, 30(5), 351-357. https://doi.org/10.1093/intqhc/mzy014
Kisely, S., Forsyth, S., & Lawrence, D. (2016). Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? The Australian and New Zealand Journal of Psychiatry, 50(3), 254-263. https://doi.org/10.1177/0004867415577979
Korpela, H., Miettunen, J., Rautio, N., Isohanni, M., Järvelin, M. R., Jääskeläinen, E., Auvinen, J., Keinänen-Kiukaanniemi, S., Nordström, T., & Seppälä, J. (2020). Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966. European Psychiatry, 63(1), e24. https://doi.org/10.1192/j.eurpsy.2020.25
Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2009). Prevalence of alcohol use disorders in schizophrenia--a systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 120(2), 85-96. https://doi.org/10.1111/j.1600-0447.2009.01385.x
Kowalski, K., & Misiak, B. (2023). Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective. Revista de Psiquiatría y Salud Mental, S1888-9891(23), 00015-0. Advance online publication. https://doi.org/10.1016/j.rpsm.2023.04.002
Kugathasan, P., Laursen, T. M., Grøntved, S., Jensen, S. E., Aagaard, J., & Nielsen, R. E. (2018). Increased long-term mortality after myocardial infarction in patients with schizophrenia. Schizophrenia Research, 199, 103-108. https://doi.org/10.1016/j.schres.2018.03.015
Kugathasan, P., Stubbs, B., Aagaard, J., Jensen, S. E., Munk Laursen, T., & Nielsen, R. E. (2019). Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study. Acta Psychiatrica Scandinavica, 140(4), 340-348. https://doi.org/10.1111/acps.13076
Kurdyak, P., Vigod, S., Duchen, R., Jacob, B., Stukel, T., & Kiran, T. (2017). Diabetes quality of care and outcomes: Comparison of individuals with and without schizophrenia. General Hospital Psychiatry, 46, 7-13. https://doi.org/10.1016/j.genhosppsych.2017.02.001
Lambert, T. J., Velakoulis, D., & Pantelis, C. (2003). Medical comorbidity in schizophrenia. The Medical Journal of Australia, 178(S9), S67-S70. https://doi.org/10.5694/j.1326-5377.2003.tb05311.x
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. JAMA, 284(20), 2606-2610. https://doi.org/10.1001/jama.284.20.2606
Laursen, T. M., Munk-Olsen, T., & Gasse, C. (2011). Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PloS One, 6(9), e24597. https://doi.org/10.1371/journal.pone.0024597
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014). Excess early mortality in schizophrenia. Annual Review of Clinical Psychology, 10, 425-448. https://doi.org/10.1146/annurev-clinpsy-032813-153657
Laursen, T. M., Plana-Ripoll, O., Andersen, P. K., McGrath, J. J., Toender, A., Nordentoft, M., Canudas-Romo, V., & Erlangsen, A. (2019). Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse? Schizophrenia Research, 206, 284-290. https://doi.org/10.1016/j.schres.2018.11.003
Lee, E. E., Liu, J., Tu, X., Palmer, B. W., Eyler, L. T., & Jeste, D. V. (2018). A widening longevity gap between people with schizophrenia and general population: A literature review and call for action. Schizophrenia Research, 196, 9-13. https://doi.org/10.1016/j.schres.2017.09.005
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007). Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica, 116(5), 317-333. https://doi.org/10.1111/j.1600-0447.2007.01095.x
Lin, G. M., Chen, Y. J., Kuo, D. J., Jaiteh, L. E., Wu, Y. C., Lo, T. S., & Li, Y. H. (2013). Cancer incidence in patients with schizophrenia or bipolar disorder: anationwide population-based study in Taiwan, 1997-2009. Schizophrenia Bulletin, 39(2), 407-416. https://doi.org/10.1093/schbul/sbr162
Lu, M. L. R., De Venecia, T. A., Goyal, A., Rodriguez Ziccardi, M., Kanjanahattakij, N., Shah, M. K., Davila, C. D, & Figueredo, V. M. (2017). Psychiatric conditions as predictors of rehospitalization among African American patients hospitalized with heart failure. Clinical Cardiology, 40(11), 1020-1025. https://doi.org/10.1002/clc.22760
Martens, P. J., Chochinov, H. M., Prior, H. J., Fransoo, R., Burland, E., & Need to Know Team. (2009). Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study. Schizophrenia Research, 113(1), 101-106. https://doi.org/10.1016/j.schres.2009.04.015
Martinez-Nicolas, I., Basaraba, C., Delgado-Gomez, D., Lopez-Fernandez, O., Baca-Garcia, E., Wainberg, M. L. (2023b). The Electronic Mental Wellness Tool as a Self-Administered Brief Screening Instrument for Mental Disorders in the General Spanish Population during the Post-COVID-19 Era. International Journal of Environmental Research and Public Health, 20(4), 3204. https://doi.org/10.3390/ijerph20043204
Martínez-Nicolás, I., Molina-Pizarro, C.A., Franco, A.R., Arenas Castañeda, P. E., Maya, C., Barahona, I., Martínez-Alés, G., Aroca Bisquert, F., Delgado-Gomez, D., Dervic, K., Lopez-Fernandez, O., Baca-García, E., & Barrigón, M. L. (2023a). What seems to explain suicidality in Yucatan Mexican young adults? Findings from an app-based mental health screening test using the SMART-SCREEN protocol. Current Psychology, 42(35), 30767-30779). https://doi.org/10.1007/s12144-022-03686-8
McGinty, E. E., Baller, J., Azrin, S. T., Juliano-Bult, D., & Daumit, G. L. (2015). Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophrenia Research, 165(2-3), 227-235. https://doi.org/10.1016/j.schres.2015.04.010
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews, 30, 67-76. https://doi.org/10.1093/epirev/mxn001
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097
Nielsen, P. R., Laursen, T. M., & Agerbo, E. (2016). Comorbidity of schizophrenia and infection: a population-based cohort study. Social Psychiatry and Psychiatric Epidemiology, 51(12), 1581-1589. https://doi.org/10.1007/s00127-016-1297-1
Nordentoft, M., Plana-Ripoll, O., & Laursen, T. M. (2021). Cancer and schizophrenia. Current Opinion in Psychiatry, 34(3), 260-265. https://doi.org/10.1097/YCO.0000000000000697
Oud, M. J., & Meyboom-de Jong, B. (2009). Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Family Practice, 10, 32. https://doi.org/10.1186/1471-2296-10-32
Oud, M. J., Schuling, J., Groenier, K. H., Verhaak, P. F., Slooff, C. J., Dekker, J. H., & Meyboom-de Jong, B. (2010). Care provided by general practitioners to patients with psychotic disorders: a cohort study. BMC Family Practice, 11, 92. https://doi.org/10.1186/1471-2296-11-92
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Pankiewicz-Dulacz, M., Stenager, E., Chen, M., & Stenager, E. N. (2019). Risk factors of major infections in schizophrenia. A nationwide Danish register study. Journal of Psychosomatic Research, 121, 60-67. https://doi.org/10.1016/j.jpsychores.2019.04.003
Partti, K., Vasankari, T., Kanervisto, M., Perälä, J., Saarni, S. I., Jousilahti, P., Lönnqvist, J., & Suvisaari, J. (2015). Lung function and respiratory diseases in people with psychosis: population-based study. The British Journal of Psychiatry, 207(1), 37-45. https://doi.org/10.1192/bjp.bp.113.141937
Poirier, M. F., Canceil, O., Baylé, F., Millet, B., Bourdel, M. C., Moatti, C., Olié, J. P., & Attar Lévy, D. (2002). Prevalence of smoking in psychiatric patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(3), 529-537. https://doi.org/10.1016/s0278-5846(01)00304-9
Polcwiartek, C., Kragholm, K., Rohde, C., Hashemi, N., Vang, T., & Nielsen, J. (2017). Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study. Diabetologia, 60(9), 1678-1690. https://doi.org/10.1007/s00125-017-4320-5
Porras-Segovia, A., Krivoy, A., Horowitz, M., Thomas, G., Bolstridge, M., Ion, D., & Shergill, S. S. (2017). Rapid-onset clozapine-induced loss of glycaemic control: case report. BJPsych Open, 3(3), 138-140. https://doi.org/10.1192/bjpo.bp.117.004481
Räsänen, S., Hakko, H., Viilo, K., Meyer-Rochow, V. B., & Moring, J. (2003). Excess mortality among long-stay psychiatric patients in Northern Finland. Social Psychiatry and Psychiatric Epidemiology, 38(6), 297-304. https://doi.org/10.1007/s00127-003-0635-2
Razzano, L. A., Cook, J. A., Yost, C., Jonikas, J. A., Swarbrick, M. A., Carter, T. M., & Santos, A. (2015). Factors associated with co-occurring medical conditions among adults with serious mental disorders. Schizophrenia Research, 161(2-3), 458-464. https://doi.org/10.1016/j.schres.2014.11.021
Rodrigues, M., Wiener, J. C., Stranges, S., Ryan, B. L., & Anderson, K. K. (2021). The risk of physical multimorbidity in people with psychotic disorders: A systematic review and meta-analysis. Journal of Psychosomatic Research, 140, 110315. https://doi.org/10.1016/j.jpsychores.2020.110315
Salokangas, R. K. (2007). Medical problems in schizophrenia patients living in the community (alternative facilities). Current Opinion in Psychiatry, 20(4), 402-405. https://doi.org/10.1097/YCO.0b013e328122d99b
Schoepf, D., Potluri, R., Uppal, H., Natalwala, A., Narendran, P., & Heun, R. (2012). Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up. European Psychiatry, 27(1), 33-42. https://doi.org/10.1016/j.eurpsy.2011.02.009
Schoepf, D., Uppal, H., Potluri, R., & Heun, R. (2014). Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. European Archives of Psychiatry and Clinical Neuroscience, 264(1), 3-28. https://doi.org/10.1007/s00406-013-0436-x
Schulman-Marcus, J., Goyal, P., Swaminathan, R. V., Feldman, D. N., Wong, S. C., Singh, H. S., Minutello, R. M., Bergman, G., & Kim, L. K. (2016). Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients with Versus Without Severe Mental Illness. The American Journal of Cardiology, 117(9), 1405-1410. https://doi.org/10.1016/j.amjcard.2016.02.006
Shen, H. N., Lu, C. L., & Yang, H. H. (2011). Increased risks of acute organ dysfunction and mortality in intensive care unit patients with schizophrenia: a nationwide population-based study. Psychosomatic Medicine, 73(7), 620-626. https://doi.org/10.1097/PSY.0b013e3182280016
Sohn, M., Moga, D. C., & Talbert, J. (2015). Mental disorder comorbidity and in-hospital mortality among patients with acute myocardial infarction. Geriatric Mental Health Care, 3(1), 7-11. https://doi.org/10.1016/j.gmhc.2015.04.002
Soontornniyomkij, V., Lee, E. E., Jin, H., Martin, A. S., Daly, R. E., Liu, J., Tu, X. M., Eyler, L. T., & Jeste, D. V. (2019). Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms. Frontiers in Psychiatry, 10, 251. https://doi.org/10.3389/fpsyt.2019.00251
Spilsbury, K., Rosenwax, L., Brameld, K., Kelly, B., & Arendts, G. (2018). Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study. PloS One, 13(11), e0208220. https://doi.org/10.1371/journal.pone.0208220
Stahl, S. M., Mignon, L., & Meyer, J. M. (2009). Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatrica Scandinavica, 119(3), 171-179. https://doi.org/10.1111/j.1600-0447.2008.01334.x
Sørensen, H. J., Nielsen, P. R., Benros, M. E., Pedersen, C. B., & Mortensen, P. B. (2015). Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals. Schizophrenia Bulletin, 41(2), 513-521. https://doi.org/10.1093/schbul/sbu110
Tanskanen, A., Tiihonen, J., & Taipale, H. (2018). Mortality in schizophrenia: 30-year nationwide follow-up study. Acta Psychiatrica Scandinavica, 138(6), 492-499. https://doi.org/10.1111/acps.12913
Tokuda, Y., Obara, H., Nakazato, N., & Stein, G. H. (2008). Acute care hospital mortality of schizophrenic patients. Journal of Hospital Medicine, 3(2), 110-116. https://doi.org/10.1002/jhm.256
Torous, J., Firth, J., Mueller, N., Onnela, J. P., & Baker, J. T. (2017). Methodology and Reporting of Mobile Heath and Smartphone Application Studies for Schizophrenia. Harvard Review of Psychiatry, 25(3), 146-154. https://doi.org/10.1097/HRP.0000000000000133
Urrútia, G., & Bonfill, X. (2010). Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis [PRISMA declaration: a proposal to improve the publication of systematic reviews and meta-analyses]. Medicina Clínica, 135(11), 507-511. https://doi.org/10.1016/j.medcli.2010.01.015
Vancampfort, D., Firth, J., Schuch, F. B., Rosenbaum, S., Mugisha, J., Hallgren, M., Probst, M., Ward, P. B., Gaughran, F., De Hert, M., Carvalho, A. F., & Stubbs, B. (2017). Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry, 16(3), 308-315. https://doi.org/10.1002/wps.20458
